New advances in hepatitis C therapy.
There is encouraging news for people with hepatitis C virus (HCV). A new form of interferon-alfa, known as peg-interferon (PEG-Intron form Schering Plough), shows better activity than the current version of the drug. This new version is bound to a chemical (called polyethylene glycol), which makes the drug active in the blood for longer periods than standard interferon-alfa. PI Perspective 29 reported on early results of a different peg-interferon (Pegasys) that also showed improved activity over the existing therapy.